Soquelitinib (formerly CPI-818) is an investigational small molecule drug given orally designed to selectively inhibit ITK (interleukin-2-inducible T cell kinase), an enzyme that is expressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback